These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33789835)

  • 1. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
    Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
    Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Surgical Fertility Preservation Procedures in Children Prior to Hematopoietic Stem Cell Transplant.
    Brodigan K; Kapadia M; Frazier AL; Laufer MR; Yu R; Weil BR; Ginsburg ES; Duncan C; Lehmann L
    Transplant Cell Ther; 2021 Aug; 27(8):696.e1-696.e4. PubMed ID: 33864966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant.
    Higgins A; Khan Z; Coddington CC; Hashmi SK; Hefazi M; Alkhateeb H; Litzow MR; Hogan WJ; Cathcart-Rake E; Thompson CA; Patnaik MM
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1232-1239. PubMed ID: 30772513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation.
    Bender JD; Oquendo-Del Toro H; Benoit J; Howell JC; Badia P; Davies SM; Grimley MS; Jodele S; Phillips C; Burns K; Marsh R; Nelson A; Wallace G; Dandoy CE; Pate A; Strine AC; Frias O; Breech L; Rose SR; Hoefgen H; Khandelwal P; Myers KC
    Transplant Cell Ther; 2023 Feb; 29(2):130.e1-130.e8. PubMed ID: 36323400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study.
    Çiftçiler R; Göker H; Demiroğlu H; Aladağ E; Aksu S; Haznedaroğlu İC; Sayınalp N; Özcebe O; Tekin F; Büyükaşık Y
    Turk J Haematol; 2019 May; 36(2):88-96. PubMed ID: 30717586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8-Gy total body irradiation-based reduced-toxicity myeloablative conditioning.
    Komori K; Hirabayashi K; Morita D; Hara Y; Kurata T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Koike K; Nakazawa Y
    Pediatr Transplant; 2019 May; 23(3):e13372. PubMed ID: 30714283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women's fertility.
    Assouline E; Crocchiolo R; Prebet T; Broussais F; Coso D; Gamerre M; Vey N; Blaise D; Courbiere B
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):704-10. PubMed ID: 24070823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.
    Nakano H; Ashizawa M; Akahoshi Y; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
    Int J Hematol; 2016 Jul; 104(1):110-6. PubMed ID: 27084256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
    Mohamed SY; Fadhil I; Hamladji RM; Hamidieh AA; Fahmy O; Ladeb S; Alimoghaddam K; Elhaddad A; Nacer RA; Alsharif F; Rasheed W; Jahani M; Mousavi SA; Alseraihy A; Abdel-Rahman F; Al Jefri A; Hussein AA; Alabdulaaly A; Ibrahim A; Bekadja MA; Abboud M; Ahmed P; Dennison D; Bakr M; Benchekroun S; Hussain F; Othman TB; Aljurf M; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2011; 4(2):81-93. PubMed ID: 21727769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of bone density, general and reproductive health in female survivors after treatment for haematological malignancies.
    Naessén S; Bergström I; Ljungman P; Landgren BM
    Eur J Haematol; 2014 Aug; 93(2):137-42. PubMed ID: 24649942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian insufficiency following allogeneic hematopoietic stem cell transplantation.
    Kawano M; Komura H; Kawaguchi H; Shimizu S; Yada-Hashimoto N; Shimizu M; Sato M; Inoue M; Ida S; Etani Y; Shoji Y; Nakacho M; Sawada K; Kimura T; Mitsuda N; Kurachi H
    Gynecol Endocrinol; 2017 Feb; 33(2):156-159. PubMed ID: 27808585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation.
    Massenkeil G; Alexander T; Rosen O; Dörken B; Burmester G; Radbruch A; Hiepe F; Arnold R
    Rheumatol Int; 2016 Nov; 36(11):1563-1568. PubMed ID: 27522225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
    Loren AW; Chow E; Jacobsohn DA; Gilleece M; Halter J; Joshi S; Wang Z; Sobocinski KA; Gupta V; Hale GA; Marks DI; Stadtmauer EA; Apperley J; Cahn JY; Schouten HC; Lazarus HM; Savani BN; McCarthy PL; Jakubowski AA; Kamani NR; Hayes-Lattin B; Maziarz RT; Warwick AB; Sorror ML; Bolwell BJ; Socié G; Wingard JR; Rizzo JD; Majhail NS
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):157-66. PubMed ID: 20659574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert consensus on fertility preservation in hematopoietic stem cell transplantation in girls in China.
    Ruan X
    Gynecol Endocrinol; 2023 Dec; 39(1):2146671. PubMed ID: 36403607
    [No Abstract]   [Full Text] [Related]  

  • 18. Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update.
    Guida M; Castaldi MA; Rosamilio R; Giudice V; Orio F; Selleri C
    J Ovarian Res; 2016 Nov; 9(1):72. PubMed ID: 27802832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.
    Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
    Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation in children with refractory cytopenia of childhood: single-center experience using high-dose cytarabine containing myeloablative and aplastic anemia oriented reduced-intensity conditioning regimens.
    Inagaki J; Fukano R; Kurauchi K; Noguchi M; Tanioka S; Okamura J
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):565-9. PubMed ID: 25498905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.